Data as of Jan 23
| +0.63 / +1.82%|
The 26 analysts offering 12-month price forecasts for Roche have a median target of 40.10, with a high estimate of 46.88 and a low estimate of 33.09. The median estimate represents a +13.47% increase from the last price of 35.34.
The current consensus among 28 polled investment analysts is to Buy stock in Roche. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.